Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
10.27
-0.51 (-4.73%)
At close: Oct 10, 2025, 4:00 PM EDT
10.10
-0.17 (-1.66%)
After-hours: Oct 10, 2025, 7:49 PM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $45.60 million as of October 10, 2025. Its market cap has increased by 41.33% in one year.
Market Cap
45.60M
Enterprise Value
39.98M
1-Year Change
41.33%
Ranking
Category
Stock Price
$10.27
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $45.60M, a decrease of -48.56%. That is a compound annual growth rate of -14.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 45.60M | 25.21% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | 88.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |